297 related articles for article (PubMed ID: 18524796)
1. Elevated serum levels of IGF-binding protein 2 in patients with non-seminomatous germ cell cancer: correlation with tumor markers alpha-fetoprotein and human chorionic gonadotropin.
Fottner C; Sattarova S; Hoffmann K; Spöttl G; Weber MM
Eur J Endocrinol; 2008 Sep; 159(3):317-27. PubMed ID: 18524796
[TBL] [Abstract][Full Text] [Related]
2. The differential regulation of the circulating levels of the insulin-like growth factors and their binding proteins (IGFBP) 1, 2 and 3 after elective abdominal surgery.
Cotterill AM; Mendel P; Holly JM; Timmins AG; Camacho-Hübner C; Hughes SC; Ross RM; Blum WF; Langford RM
Clin Endocrinol (Oxf); 1996 Jan; 44(1):91-101. PubMed ID: 8706300
[TBL] [Abstract][Full Text] [Related]
3. Serum insulin-like growth factor (IGF)-I and IGF-binding proteins in lung cancer patients.
Lee DY; Kim SJ; Lee YC
J Korean Med Sci; 1999 Aug; 14(4):401-4. PubMed ID: 10485619
[TBL] [Abstract][Full Text] [Related]
4. Decreased bioavailability of insulin-like growth factor-I, a cause of catabolism in hemodialysis patients?
Lindgren BF; Odar-Cederlöf I; Ericsson F; Brismar K
Growth Regul; 1996 Sep; 6(3):137-43. PubMed ID: 8894646
[TBL] [Abstract][Full Text] [Related]
5. Expression of serum insulin-like growth factors, insulin-like growth factor-binding proteins, and the growth hormone-binding protein in heterozygote relatives of Ecuadorian growth hormone receptor deficient patients.
Fielder PJ; Guevara-Aguirre J; Rosenbloom AL; Carlsson L; Hintz RL; Rosenfeld RG
J Clin Endocrinol Metab; 1992 Apr; 74(4):743-50. PubMed ID: 1372321
[TBL] [Abstract][Full Text] [Related]
6. Elevated serum insulin-like growth factor-binding protein 2 (IGFBP-2) and decreased IGFBP-3 in epithelial ovarian cancer: correlation with cancer antigen 125 and tumor-associated trypsin inhibitor.
Flyvbjerg A; Mogensen O; Mogensen B; Nielsen OS
J Clin Endocrinol Metab; 1997 Jul; 82(7):2308-13. PubMed ID: 9215312
[TBL] [Abstract][Full Text] [Related]
7. Urinary insulin-like growth factors (IGF) and IGF-binding proteins in normal subjects, growth hormone deficiency, and renal disease.
Gargosky SE; Hasegawa T; Tapanainen P; MacGillivray M; Hasegawa Y; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Jun; 76(6):1631-7. PubMed ID: 7684745
[TBL] [Abstract][Full Text] [Related]
8. Sequential changes in insulin-like growth factor I (IGF-I) and IGF-binding proteins in children with end-stage liver disease before and after successful orthotopic liver transplantation.
Holt RI; Jones JS; Stone NM; Baker AJ; Miell JP
J Clin Endocrinol Metab; 1996 Jan; 81(1):160-8. PubMed ID: 8550746
[TBL] [Abstract][Full Text] [Related]
9. Growth retardation in constitutionally short children is related both to low serum levels of insulin-like growth factor-I and to its reduced bioavailability.
Lindgren BF; Segovia B; Lassarre C; Binoux M; Gourmelen M
Growth Regul; 1996 Sep; 6(3):158-64. PubMed ID: 8894649
[TBL] [Abstract][Full Text] [Related]
10. Elevated levels of insulin-like growth factor-binding protein-2 in the serum of prostate cancer patients.
Cohen P; Peehl DM; Stamey TA; Wilson KF; Clemmons DR; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Apr; 76(4):1031-5. PubMed ID: 7682560
[TBL] [Abstract][Full Text] [Related]
11. The effect of dietary protein supplementation on insulin-like growth factors (IGFs) and IGF-binding proteins in children with shigellosis.
Pucilowska JB; Davenport ML; Kabir I; Clemmons DR; Thissen JP; Butler T; Underwood LE
J Clin Endocrinol Metab; 1993 Dec; 77(6):1516-21. PubMed ID: 7505287
[TBL] [Abstract][Full Text] [Related]
12. [The expressions and clinical significance of IGFBP-2, -3 in both serum and tumor tissues in patients with epithelial ovarian cancer].
Yan XJ; Tian Y; Wang C; Wang XL; Di JM; Cheng JX
Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Jul; 40(4):639-43. PubMed ID: 19764562
[TBL] [Abstract][Full Text] [Related]
13. Monitoring of patients with non-seminomatous germ cell tumors of the testis by determination of alpha-fetoprotein and beta-human chorionic gonadotropin levels and by computed tomography.
Kausitz J; Ondrus D; Belan V; Matoska J
Neoplasma; 1992; 39(6):357-61. PubMed ID: 1283444
[TBL] [Abstract][Full Text] [Related]
14. Insulin-like growth factors stimulate the release of insulin-like growth factor-binding protein-3 (IGFBP-3) and degradation of IGFBP-4 in nonsmall cell lung cancer cell lines.
Noll K; Wegmann BR; Havemann K; Jaques G
J Clin Endocrinol Metab; 1996 Jul; 81(7):2653-62. PubMed ID: 8675593
[TBL] [Abstract][Full Text] [Related]
15. Increased levels of insulin-like growth factor II (IGF-II) and IGF-binding protein-2 are associated with malignancy in sporadic adrenocortical tumors.
Boulle N; Logié A; Gicquel C; Perin L; Le Bouc Y
J Clin Endocrinol Metab; 1998 May; 83(5):1713-20. PubMed ID: 9589681
[TBL] [Abstract][Full Text] [Related]
16. The GH-IGF-IGFBP axis is changed in Turner syndrome: partial normalization by HRT.
Gravholt CH; Chen JW; Oxvig C; Overgaard MT; Christiansen JS; Frystyk J; Flyvbjerg A
Growth Horm IGF Res; 2006; 16(5-6):332-9. PubMed ID: 17067837
[TBL] [Abstract][Full Text] [Related]
17. Serum-free insulin-like growth factor I correlates with clearance in patients with chronic renal failure.
Frystyk J; Ivarsen P; Skjaerbaek C; Flyvbjerg A; Pedersen EB; Orskov H
Kidney Int; 1999 Dec; 56(6):2076-84. PubMed ID: 10594783
[TBL] [Abstract][Full Text] [Related]
18. Various components of the insulin-like growth factor system in tumor tissue, cerebrospinal fluid and peripheral blood of pediatric medulloblastoma and ependymoma patients.
de Bont JM; van Doorn J; Reddingius RE; Graat GH; Passier MM; den Boer ML; Pieters R
Int J Cancer; 2008 Aug; 123(3):594-600. PubMed ID: 18478565
[TBL] [Abstract][Full Text] [Related]
19. Pilot study of elevated levels of insulin-like growth factor-binding protein-2 as indicators of hepatocellular carcinoma.
Ranke MB; Maier KP; Schweizer R; Stadler B; Schleicher S; Elmlinger MW; Flehmig B
Horm Res; 2003; 60(4):174-80. PubMed ID: 14530605
[TBL] [Abstract][Full Text] [Related]
20. The composition and distribution of insulin-like growth factors (IGFs) and IGF-binding proteins (IGFBPs) in the serum of growth hormone receptor-deficient patients: effects of IGF-I therapy on IGFBP-3.
Gargosky SE; Wilson KF; Fielder PJ; Vaccarello MA; Guevara-Aguirre J; Diamond FB; Baxter RC; Rosenbloom AL; Rosenfeld RG
J Clin Endocrinol Metab; 1993 Dec; 77(6):1683-9. PubMed ID: 7505289
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
